DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Filed By Glancy Binkow & Goldberg LLP

INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Filed By Glancy Binkow & Goldberg LLP

INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Filed By Glancy Binkow & Goldberg LLP

Blackstone-backed Catalent sets terms for $871 million IPO

UPDATE 1-Catalent expects IPO to be priced between $19-$22/shr

Tasmania, Big Supplier to Drug Companies, Faces Changes

Taking Cancer Drug With Food May Cut Costs

FDA Panel: 3 Asthma Drugs Can Stay

FDA Panel Seems Skeptical Over Key Avandia Data

Theravance/Glaxo Commence Global Late stage Study on COPD